药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Podofilox
Tetrandrine
The risk or severity of adverse effects can be increased when Pazopanib is combined with Tetrandrine.
Podofilox
Bleselumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Bleselumab.
Podofilox
Rozanolixizumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Rozanolixizumab.
Podofilox
Risankizumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Risankizumab.
Podofilox
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Pazopanib is combined with Monomethyl fumarate.
Podofilox
Fluclorolone
The risk or severity of adverse effects can be increased when Pazopanib is combined with Fluclorolone.
Podofilox
Fluperolone
The risk or severity of adverse effects can be increased when Pazopanib is combined with Fluperolone.
Podofilox
Begelomab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Begelomab.
Podofilox
Fluocortin
The risk or severity of adverse effects can be increased when Pazopanib is combined with Fluocortin.
Podofilox
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Pazopanib is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Podofilox
Hypericin
The risk or severity of adverse effects can be increased when Pazopanib is combined with Hypericin.
Podofilox
Acteoside
The risk or severity of adverse effects can be increased when Pazopanib is combined with Acteoside.
Podofilox
Deoxyspergualin
The risk or severity of adverse effects can be increased when Pazopanib is combined with Deoxyspergualin.
Podofilox
Doxifluridine
The risk or severity of adverse effects can be increased when Pazopanib is combined with Doxifluridine.
Podofilox
Trofosfamide
The risk or severity of adverse effects can be increased when Pazopanib is combined with Trofosfamide.
Podofilox
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Pazopanib is combined with Cepeginterferon alfa-2B.
Podofilox
Gusperimus
The risk or severity of adverse effects can be increased when Pazopanib is combined with Gusperimus.
Podofilox
Mizoribine
The risk or severity of adverse effects can be increased when Pazopanib is combined with Mizoribine.
Podofilox
Triptolide
The risk or severity of adverse effects can be increased when Pazopanib is combined with Triptolide.
Podofilox
Ocrelizumab
The risk or severity of adverse effects can be increased when Pazopanib is combined with Ocrelizumab.